Complications of Trans-Rectal Ultrasound-Guided Prostate Biopsy: A Single-Centre Experience from Sindh Institute of Urology and Transplantation

Authors

  • Abdul Rehman Author
  • Hafiz Dur-e-Furqani Author
  • Shireen Pyarali Author
  • Faiz Pasha Author
  • Tanzeel Ur Rahman Gazder Author
  • Rehan Mohsin Author

DOI:

https://doi.org/10.51985/JBUMDC2025686

Abstract

 Objective: To evaluate the frequency, severity, and types of complications associated with TRUS-guided prostate biopsy in patients at the Sindh Institute of Urology and Transplantation (SIUT) over an 18-month period.

 

Study Design and Setting: This observational study included 302 male patients who underwent TRUS-guided prostate biopsy between January 2023 and June 2024.

 

Methodology: Pain severity was measured using the Visual Analog Scale (VAS). Complications such as haematuria, urinary tract infections, hematospermia, rectal bleeding, acute urinary retention, and epididymo-orchitis were documented. Descriptive statistics were used for data analysis.

 

Results: Acute urinary retention (6,2%) , urinary tract infection (6.2%) , visible haematuria (8.5%)and probe-related pain (VAS 9= 11.8%) were observed in patient underwent TRUS-guided biopsy. Hematospermia and epididymo-orchitis were seen in 10.2% and 15.8% of cases. Rectal bleeding was least common (3.3%).

 

Conclusion: TRUS-guided prostate biopsy is associated with significant procedural discomfort and a notable incidence of post-procedure complications. Enhanced pain management protocols and infection prevention strategies are essential to improve patient outcomes and procedural safety.

 

Keywords: Trans rectal ultrasound guided prostate biopsy, Infection, Acute urinary retention 

Downloads

Download data is not yet available.

References

1. Bennett HY, Roberts MJ, Doi SAR, Gardiner RA. The global

burden of prostate cancer: current and emerging trends.

Prostate Int. 2021;9(2):65–69. doi: 10.1016/j.prnil.2021.04.0042. Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication

rates and risk factors of 5802 transrectal ultrasound-guided

prostate biopsies: a prospective study. J Urol. 2020;204(1):

120–125. doi:10.1097/JU.0000000000000812

3. Borghesi M, Ahmed H, Nam R, et al. Complications after

systematic, random, and image-guided prostate biopsy. Eur

Urol. 2020;77(1):18–30. doi: 10.1016/j.eururo.2019.09.006

4. Ekwueme K, Simpson H, Zilvetti M, et al. Pain and infection

rates after transrectal ultrasound-guided prostate biopsy: a

prospective study. BJU Int. 2021;127(6):676–682. doi:10.1111/

bju.15254

5. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review

of complications of prostate biopsy. Eur Urol. 2021;80(3):

345–353. doi: 10.1016/j.eururo.2021.05.009

6. Kehinde EO, Al-Maghrebi M, Al-Hunayan A, et al. Antibiotic

resistance and prophylaxis for transrectal prostate biopsy:

2020 update. Arab J Urol. 2021;19(2):130–139. doi:10.1080/

2090598X.2021.1880110

7. Chiang PH, Liu SP, Chien KY, et al. Comparison of

fluoroquinolone vs cephalosporin prophylaxis for prostate

biopsy: a multicenter study. BMC Infect Dis. 2022;22(1):77.

doi:10.1186/s12879-022-07021-2

8. Wagenlehner FME, van Oostrum E, Tenke P, et al. Infective

complications after prostate biopsy: evaluation of risk factors.

World J Urol. 2020;38(1):135–143. doi:10.1007/s00345-019-

02718-z

9. Lee J, Kim JH, Choi SH, et al. Predictors of acute urinary

retention after prostate biopsy. Prostate Int. 2021;9(4):181–186.

doi: 10.1016/j.prnil.2021.07.002

10. Loeb S, Carter HB, Berndt SI, et al. Complications after

prostate biopsy: data from the Prostate Cancer Prevention

Trial. J Urol. 2020;203(2):313–317. doi:10.1097/JU.

0000000000000524

11. De Nunzio C, Lombardo R, Leonardo C, et al. Erectile

dysfunction after prostate biopsy: clinical relevance and

associated factors. World J Urol. 2021;39(2):491–497.

doi:10.1007/s00345-020-03156-1

12. Müller A, Lehmann K, Weber A, et al. Fournier's gangrene

after prostate biopsy: a rare complication. Case Rep Urol.

2022; 2022:9832916. doi:10.1155/2022/9832916

13. Shifa W, Shohab D, Khawaja MA, Masood A, Iqbal MW,

Akhter S. Outcome of trans-rectal ultrasound guided twelvecore biopsy of prostate for detection of prostate cancer: a

single-centre experience. J Ayub Med Coll Abbottabad.

2021;33(3): XXX–XXX. doi:10.29309/TPMJ/2021.28.02.4779

14. Xiang S, Wang X, Liu Y, et al. A systematic comparison of

transperineal versus transrectal prostate biopsy: which is

better? Front Surg. 2020; 7:583177. doi:10.3389/fsurg.2020.

583177

15. Alfano A, Paoli G, Martini A, et al. Complication Rates After

TRUS Guided Transrectal Prostate Biopsy. Front Surg. 2020;

7:7. doi:10.3389/fsurg.2020.00007

16. Ekwueme OC, et al. Complications following TRUS-guided

prostate biopsy: narrative review. J Clin Med. 2023;13(2):487.

doi:10.3390/jcm13020487

17. Comparative meta-analysis: TP vs TR complications show

lower rectal bleeding, fever, and retention with TP biopsy.

Transl Androl Urol. 2025;14(3):150. doi:10.21037/tau-2025-

150

18. Galenos J Urol Surg. Targeted antibiotic prophylaxis using

rectal swabs reduces post-biopsy infections. J Urol Surg.

2023;6(6):186-92. doi: 10.52338/jus.galenos.2023.6.6

19. World J Urol. Role of alpha-blockers in reducing urinary

retention post-biopsy. 2024; ahead-of-print. doi:10.1007/

s00345-024-05001-5

20. Thompson et al. Prospective evaluation of trans-rectal biopsy

impact on LUTS and QoL. African J Urol. 2020;26(1):62.

doi:10.1186/s12301-020-00062-5

Downloads

Published

2026-04-21

Issue

Section

Original Articles

How to Cite

Complications of Trans-Rectal Ultrasound-Guided Prostate Biopsy: A Single-Centre Experience from Sindh Institute of Urology and Transplantation. (2026). Journal of Bahria University Medical and Dental College, 16(02), 501-505. https://doi.org/10.51985/JBUMDC2025686

Most read articles by the same author(s)